Athersys Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ATHX Nasdaq 2834 http://www.athersys.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Athersys Inc

Athersys Announces Successful Type B Meeting with the FDA - Mar 22nd, 2023 12:30 pm
Athersys Expands IP Protection with First New Patent for SIFU® Technology - Feb 28th, 2023 1:15 pm
Athersys is a 'very different company' from a year ago, CEO says - Feb 14th, 2023 8:40 pm
Athersys Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion - Feb 14th, 2023 1:33 pm
Athersys to Host Business Update Conference Call on February 14th - Feb 2nd, 2023 1:30 pm
Athersys to Participate in International Stroke Conference and BioProcess International - Jan 30th, 2023 4:20 pm
Athersys shares take a wild ride while executives meet with investors - Jan 12th, 2023 12:15 am
Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit Europe in January - Jan 11th, 2023 5:11 pm
Athersys shares rise as company managers meet with investors - Jan 10th, 2023 4:59 pm
Athersys Provides MultiStem Clinical Update - Jan 9th, 2023 1:30 pm
Athersys appoints biotech veteran to board of directors - Jan 6th, 2023 8:25 pm
Athersys Appoints Joseph Nolan to Its Board of Directors - Jan 5th, 2023 9:33 pm
Athersys, Inc. (NASDAQ:ATHX) Q3 2022 Earnings Call Transcript - Dec 28th, 2022 2:59 pm
Athersys talking to 'new potential partners' for its stem cell technology - Nov 15th, 2022 8:44 pm
Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update - Nov 15th, 2022 1:00 pm
Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.’s Biotech Conference - Nov 11th, 2022 1:30 pm
Athersys, Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offering - Nov 10th, 2022 8:12 pm
Athersys Reschedules Third Quarter Conference Call to November 15 - Nov 10th, 2022 1:55 pm
Athersys may 'need to cease operations' if debt restructuring fails - Nov 9th, 2022 4:58 pm
Athersys, Inc. Announces Pricing of $5.5 Million Public Offering - Nov 9th, 2022 1:59 pm